1 / 22

Pre-Term Labor

Pre-Term Labor. Christopher R. Graber, MD Salina Women’s Clinic September 27, 2011 (revised from Mar 2010). Introduction. Definitions Random Facts Risk Factors for PTL Tocolytics Gr. tokos : childbirth, lytic : capable of dissolving Identifying patients at high risk

hija
Télécharger la présentation

Pre-Term Labor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pre-Term Labor Christopher R. Graber, MD Salina Women’s Clinic September 27, 2011 (revised from Mar 2010)

  2. Introduction • Definitions • Random Facts • Risk Factors for PTL • Tocolytics • Gr. tokos: childbirth, lytic: capable of dissolving • Identifying patients at high risk • Preterm contractions alone • Recommendations • References

  3. Definitions • Term: 37-42 wga • Preterm: between 20 and 37 wga • Labor: contractions causing cervical change • Insufficient cervix: painless cervical dilation, usually before 20 weeks • Tocolytic: any medicine given to inhibit myometrial contractions • EtOH, MgSO4, CCA, betamimetics, NSAIDs

  4. Random Facts • Preterm birth is a leading cause of neonatal morbidity and mortality • In the US, 11.5% of all births are preterm • 35% of health care $$ for infants • 75% of neonatal mortality • 50% of long-term neurologic impairments • The incidence of preterm birth is essentially the same as 40 years ago

  5. Risk Factors for PTL • Multiple gestations • Prior preterm birth • Preterm premature ROM • Bacterial vaginosis (unclear if Rx helps) • Genitial infections • Periodontal disease • Environmental factors • Smoking, drug use • Long periods of standing – 1 study

  6. Tocolytics • Etoh – mid 20th century • MgSO4 – most commonly used, controversial • Calcium Channel Blockers – newer • Nifedipine (Procardia) • Betamimetics – most common outpatient • Ritodrine, turbutaline • Oxytocin antagonists – experimental • Atosiban

  7. Tocolytics • May prolong gestation for 2-7 days • Allow for steroids and/or transport • Betamethasone 12mg IM q24h x 2 doses • No clear “first-line” drug • Side effects are common, adverse events are rare but serious • Do NOT combine tocolytics

  8. Controversy for MgSO4

  9. MgSO4 vs. Nifedipine • 2005: 192 patients, 24 to 33.6 wga, randomized to MgSO4 or Nifedipine • Primary outcome: arrest of preterm labor – prevention of delivery for 48 hours with uterine quiesence • Primary outcome – MgSO4 87% vs. Nifedipine (72%) • No differences – del within 48h, gestational age at del, birth prior to 37 or 32 weeks. • MgSO4 newborns spent more time in NICU • Mild and severe adverse effects more common in MgSO4 group

  10. MgSO4 for Neuroprotection • ACOG Committee Opinion 455, March 2010 • Observational studies in ‘90’s showed fewer neurologic complications if MgSO4 exposure for preterm del • Led to several large studies • Meta-analysis suggests that MgSO4 decreases risk for cerebral palsy (RR 0.71, 95% confidence 0.55-0.91) • No effect on fetal/infant death • Serious maternal complications not more common

  11. MgSO4 for Neuroprotection

  12. High Risk? • Who to treat? • Probability of progressive labor, gestational age, risks of treatment • Regular uterine activity that does not decrease with bed rest and hydration • Contraindications • Severe preeclampsia, active vaginal bleeding (abruption), chorio, lethal abnormalities, advanced dilation, fetal indications

  13. Identify High Risk Patients • Document cervical dilation (?change) • Consider fetal fibronectin • NPV 99%, PPV 50% for delivery in 2 weeks • No bleeding, cvx <3cm, NPV for 24h • Consider cervical sono • Transvaginal most accurate

  14. Prior Preterm Birth Recurrence risk of spontaneous preterm birth at <35wga in women with a prior preterm birth Fetal fibronectin and cervical length (transvaginal) assessed at 24wga. From: Iams JD, et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. Am Journal of Obstetrics and Gynecology. 1998; 178: 1035-1040.

  15. Preterm Contractions • Preterm contractions do not reliably predict cervical change • Study: 760 women presenting with symptoms • 18% delivered before 37wga • 3% delivered within 2 weeks of first presentation • Bed rest, pelvic rest, hydration • Uncertain benefits, never proven • Possible side effects: DVT, no income

  16. Other random facts • Women with multiple gestations are at high risk for PTL but are also at high risk for pulmonary edema with MgSO4 or turbutaline. • Repeated courses of tocolysis? • Limited benefits for initial course • Only for transport • MgSO4 for neuroprotection? • Consider amniocentesis for FLM

  17. Recommendations – Level A • No clear “first-line” tocolytic drugs • Antibiotics do not appear to prolong gestation • Reserve for GBS prophylaxis • Neither maintenance treatment with tocolytics nor repeated acute tocolysis improve perinatal outcomes

  18. Recommendations – Level A • Tocolytics may prolong pregnancy 2-7 days to allow for transport and ANCS (the most beneficial intervention for true PTL) • There are no current data to support the use of salivary estriol, Home Uterine Activity Monitoring (HUAM), or BV screening as strategies to identify or prevent PTL

  19. Recommendations – Level B • Cervical ultrasound and/or fetal fibronectin have good negative predictive value and may be useful in determining women at high risk • Amniocentesis for FLM may be used during preterm labor episodes • Bed rest, hydration, and pelvic rest do not appear to improve the rate of preterm birth

  20. References • ACOG Practice Bulletin. Assessment of Risk Factors for Preterm Birth. Number 31, October 2001, reaffirmed 2008. • ACOG Practice Bulletin. Management of Preterm Labor. Number 43, May 2003, reaffirmed 2008. • ACOG Committee Opinion . Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection. Number 455, March 2010. • Elliott, JP, et al. In Defense of Magnesium Sulfate. Obstetrics & Gynecology. 113(6):1341-1348, June 2009. • Grimes, DA, et al. Magnesium Sulfate Tocolysis: Time to Quit . Obstetrics & Gynecology. 108(4):986-989, October 2006. • Iams JD, et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. Am erican Journal of Obstetrics and Gynecology. 1998; 178: 1035-1040. • Lyell DJ. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstetrics & Gynecology July 2007; 110(1): 61-7.

More Related